14 research outputs found
Influence of the type of anaesthetic support on the development of postoperative cognitive dysfunction in gynecologic oncology patients
Aim. Determination of the influence of age and type of anesthesia on the patientβs cognitive abilities.
Methods. 30 females who underwent surgical intervention were examined. The first group consisted of 14 patients who received general inhalational anesthesia, group 2 included 16 patients who received general inhalational anesthesia in combination with epidural anesthesia. All patients underwent neuropsychological testing at several stages: one day before the surgery, the first day after surgery, on day 28 after the surgery. Cognitive status was assessed using Mini-Mental State Examination (MMSE) and the clock-drawing test (CLOCK).
Results. Given the combination of indices of both types of neuropsychological testing, postoperative cognitive dysfunction was diagnosed when a decrease by 10% or more of both MMSE and clock-drawing test and the MMSE score in patients with diagnosed postoperative cognitive dysfunction was less than 24 on both days 1 and 28. It should be noted that the results of testing before surgery in all groups of patients showed mild cognitive dysfunction. After the surgery, the measures of intellectual ability significantly decreased. The results of the analysis in the early recovery period in the group of patients who underwent combined anesthesia were significantly higher. And in the group of patients with combined anesthesia compared to the group that received only general anesthesia on day 28, cognitive indices were significantly higher: MMSE β pMW=0.041 and CLOCK β pMW
Conclusion. General anesthesia combined with epidural anesthesia affects cognitive function of female patients less negatively than the use of general anesthesia alone
Biological markers as predictors of postoperative neurocognitive disorders
Aim of the study: to highlight the main discussed tactical points of anesthesiologist's management of patients, to outline more promising aspects of biochemical laboratory diagnosis of postoperative neurocognitive disorders.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β Π²ΡΠ΄Π΅Π»ΠΈΡΡ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΎΠ±ΡΡΠΆΠ΄Π°Π΅ΠΌΡΠ΅ ΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠΎΠΌΠ΅Π½ΡΡ Π²Π΅Π΄Π΅Π½ΠΈΡ Π°Π½Π΅ΡΡΠ΅Π·ΠΈΠΎΠ»ΠΎΠ³ΠΎΠΌ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², ΠΎΠ±ΠΎΠ·Π½Π°ΡΠΈΡΡ Π±ΠΎΠ»Π΅Π΅ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
Π½Π΅ΠΉΡΠΎΠΊΠΎΠ³Π½ΠΈΡΠΈΠ²Π½ΡΡ
ΡΠ°ΡΡΡΡΠΎΠΉΡΡ
Π Π°ΠΊ ΠΌΠΎΡΠ΅Π²ΠΎΠ³ΠΎ ΠΏΡΠ·ΡΡΡ ΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄Π° fast track Π² ΡΠ°Π½Π½Π΅ΠΉ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ ΠΎΠ½ΠΊΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² (ΠΎΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ)
In the last 20 years, a concept of using multimodal programs of early rehabilitation of patients after surgical interventions β Enhanced Recovery After Surgery (ERAS) β has been developed in medicine. In oncological urology, the ERAS protocol is used only in treatment of bladder cancer. At the same time, not all available elements of this program are used despite the fact that in Russia 24.4 % of malignant tumors are urogenital tumors, and bladder cancer comprises one sixth (4.6 %) of them. Frequently, reconstructive plastic surgery is an integral part of bladder cancer treatment, and itβs accompanied by various complications many of which are associated with incorrect tactics of perioperative patient care. This situation can be dramatically improved by a more widespread use of the ERAS protocol. The immediate problemΒ of oncological urology is development of an effective, safe, and available for wide use algorithm of postoperative rehabilitation of patients with malignant tumors of the bladder after cystectomy with cystoplasty.Π ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Π΅ 20 Π»Π΅Ρ Π½Π°Π·Π°Π΄ ΠΏΠΎΡΠ²ΠΈΠ»Π°ΡΡ ΠΊΠΎΠ½ΡΠ΅ΠΏΡΠΈΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΌΡΠ»ΡΡΠΈΠΌΠΎΠ΄Π°Π»ΡΠ½ΡΡ
ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌ ΡΠ°Π½Π½Π΅ΠΉ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΠΎΡΠ»Π΅ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ² β Enhanced Recovery After Surgery (ERAS). Π ΠΎΠ½ΠΊΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΏΡΠΎΡΠΎΠΊΠΎΠ» ERAS ΠΏΡΠΈΠΌΠ΅Π½ΡΠ΅ΡΡΡ ΡΠΎΠ»ΡΠΊΠΎ ΠΏΡΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠΈ ΡΠ°ΠΊΠ° ΠΌΠΎΡΠ΅Π²ΠΎΠ³ΠΎ ΠΏΡΠ·ΡΡΡ (Π ΠΠ). ΠΡΠΈ ΡΡΠΎΠΌ ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΡΡΡΡ Π½Π΅ Π²ΡΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠ΅ ΡΠ»Π΅ΠΌΠ΅Π½ΡΡ Π΄Π°Π½Π½ΠΎΠΉ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΡ, ΠΈ ΡΡΠΎ Π½Π΅ΡΠΌΠΎΡΡΡ Π½Π° ΡΠΎ, ΡΡΠΎ Π² Π ΠΎΡΡΠΈΠΈ Π² ΡΡΡΡΠΊΡΡΡΠ΅ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠΉ 24,4 % Π·Π°Π½ΠΈΠΌΠ°ΡΡ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΎΡΠ³Π°Π½ΠΎΠ² ΠΌΠΎΡΠ΅ΠΏΠΎΠ»ΠΎΠ²ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ, ΡΡΠ΅Π΄ΠΈ Π½ΠΈΡ
ΡΠ΅ΡΡΡΡ ΡΠ°ΡΡΡ (4,6 %) ΡΠΎΡΡΠ°Π²Π»ΡΠ΅Ρ Π ΠΠ. Π§Π°ΡΡΠΎ Π½Π΅ΠΎΡΡΠ΅ΠΌΠ»Π΅ΠΌΡΠΌ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½ΡΠΎΠΌ Π»Π΅ΡΠ΅Π½ΠΈΡ Π ΠΠ ΡΠ²Π»ΡΡΡΡΡ ΡΠ΅ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠ²Π½ΠΎ-ΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ, ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°ΡΡΠΈΠ΅ΡΡ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌΠΈ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡΠΌΠΈ, ΠΌΠ½ΠΎΠ³ΠΈΠ΅ ΠΈΠ· ΠΊΠΎΡΠΎΡΡΡ
ΡΠ²ΡΠ·Π°Π½Ρ Ρ Π½Π΅Π²Π΅ΡΠ½ΠΎΠΉ ΡΠ°ΠΊΡΠΈΠΊΠΎΠΉ ΠΏΠ΅ΡΠΈΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². ΠΠ°ΡΠ΄ΠΈΠ½Π°Π»ΡΠ½ΠΎ ΠΈΠ·ΠΌΠ΅Π½ΠΈΡΡ ΡΡΡ ΡΠΈΡΡΠ°ΡΠΈΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ Π±Π»Π°Π³ΠΎΠ΄Π°ΡΡ Π±ΠΎΠ»Π΅Π΅ ΡΠΈΡΠΎΠΊΠΎΠΌΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Π° ERAS. ΠΠ»ΠΈΠΆΠ°ΠΉΡΠ°Ρ Π°ΠΊΡΡΠ°Π»ΡΠ½Π°Ρ Π·Π°Π΄Π°ΡΠ° ΠΎΠ½ΠΊΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΠΈ β ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ, Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΠ³ΠΎ ΠΈ Π΄ΠΎΡΡΡΠΏΠ½ΠΎΠ³ΠΎ Π΄Π»Ρ ΡΠΈΡΠΎΠΊΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π°Π»Π³ΠΎΡΠΈΡΠΌΠ° ΡΠ°Π½Π½Π΅ΠΉ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΠΎ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΌΠΈ Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΡΠΌΠΈ ΠΌΠΎΡΠ΅Π²ΠΎΠ³ΠΎ ΠΏΡΠ·ΡΡΡ, ΠΏΠ΅ΡΠ΅Π½Π΅ΡΡΠΈΡ
ΡΠΈΡΡΡΠΊΡΠΎΠΌΠΈΡ Ρ ΡΠΈΡΡΠΎΠΏΠ»Π°ΡΡΠΈΠΊΠΎΠΉ
Experience in the successful application of extracorporeal methods in treatment of tumor lysis syndrome
Introduction. This article, using a clinical case as an example, reflects the problem of the development of tumor lysis syndrome (TLS). The most common cause of SLO development is antitumor treatment: radiation therapy, radiofrequency ablation, vascular embolization, the use of monoclonal antibodies, high-dose chemotherapy with transplantation of stasis from peripheral blood. This disorder leads to the development of metabolic, hemodynamic, respiratory and renal disorders. The TLS distinguished by high mortality rates, from 17% to 70%.ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. Π Π΄Π°Π½Π½ΠΎΠΉ ΡΡΠ°ΡΡΠ΅ Π½Π° ΠΏΡΠΈΠΌΠ΅ΡΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ»ΡΡΠ°Ρ ΠΎΡΡΠ°ΠΆΠ΅Π½Π° ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° Π»ΠΈΠ·ΠΈΡΠ° ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ (Π‘ΠΠ). Π§Π°ΡΠ΅ Π²ΡΠ΅Π³ΠΎ ΠΏΡΠΈΡΠΈΠ½ΠΎΠΉ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π‘ΠΠ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΏΡΠΎΡΠΈΠ²ΠΎΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅: Π»ΡΡΠ΅Π²Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ, ΡΠ°Π΄ΠΈΠΎΡΠ°ΡΡΠΎΡΠ½Π°Ρ Π°Π±Π»ΡΡΠΈΡ, ΡΠΌΠ±ΠΎΠ»ΠΈΠ·Π°ΡΠΈΡ ΡΠΎΡΡΠ΄ΠΎΠ², ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΡ
Π°Π½ΡΠΈΡΠ΅Π», Π²ΡΡΠΎΠΊΠΎΠ΄ΠΎΠ·Π½Π°Ρ Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΡ Ρ ΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°ΡΠΈΠ΅ΠΉ Π‘Π’Π ΠΈΠ· ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ. ΠΠ°Π½Π½ΠΎΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΈΡ
, Π³Π΅ΠΌΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
, ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΈ ΡΠ΅Π½Π°Π»ΡΠ½ΡΡ
Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ Π‘ΠΠ, ΠΎΡΠ»ΠΈΡΠ°Π΅Ρ Π²ΡΡΠΎΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΡΡΠΈ β ΠΎΡ 17% Π΄ΠΎ 70
The role of clinical histological justification of the diagnosis in the protocol of early rehabilitation after surgical treatment of bladder cancer
In the structure of malignant neoplasms (EIT) bladder cancer (RMP) in 2015 amounted to 2.7%. For ten years, the incidence of the RMP remains at the same level of 9.3 to 11.9 cases per 100 thousand population. More than 90.0% of the patients aged 59 to 92 years (mean age of 75.5Β±12,6). Much of the effectiveness of rehabilitation is the tactics of postoperative management of patients from surgeons, oncologists and anesthesiologists-resuscitators. Conducting cystoscopy with biopsy of the tumor at the ambulatory stage, an early macro - and microscopic evaluation of the tumor allows to assess the prognostic risk factors and to plan radical treatment. The possibility of early rehabilitation and ERAS protocols used in urologic practice is rare and not fully. Using elements of the ERAS Protocol in patients with bladder tumors does not require additional costs, reduces the time patients stay in the intensive care unit for 1-2 days.Π ΡΡΡΡΠΊΡΡΡΠ΅ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠΉ (ΠΠΠ) ΡΠ°ΠΊ ΠΌΠΎΡΠ΅Π²ΠΎΠ³ΠΎ ΠΏΡΠ·ΡΡΡ (Π ΠΠ) Π² 2015 Π³ΠΎΠ΄Ρ ΡΠΎΡΡΠ°Π²ΠΈΠ» 2,7%. ΠΠ° Π΄Π΅ΡΡΡΡ Π»Π΅Ρ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΡ Π ΠΠ ΠΎΡΡΠ°Π΅ΡΡΡ ΠΏΡΠΈΠΌΠ΅ΡΠ½ΠΎ Π½Π° ΠΎΠ΄Π½ΠΎΠΌ ΡΡΠΎΠ²Π½Π΅ ΠΎΡ 9,3 Π΄ΠΎ 11,9 ΡΠ»ΡΡΠ°Π΅Π² Π½Π° 100 ΡΡΡΡΡ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ. ΠΠΎΠ»Π΅Π΅ 90,0% ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 59 Π΄ΠΎ 92 Π»Π΅Ρ (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ - 75,5+12,6). ΠΠ½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ΅ ΠΌΠ΅ΡΡΠΎ Π² ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ Π·Π°Π½ΠΈΠΌΠ°Π΅Ρ ΡΠ°ΠΊΡΠΈΠΊΠ° ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΠΎ ΡΡΠΎΡΠΎΠ½Ρ Ρ
ΠΈΡΡΡΠ³ΠΎΠ²-ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΎΠ² ΠΈ Π°Π½Π΅ΡΡΠ΅Π·ΠΈΠΎΠ»ΠΎΠ³ΠΎΠ²-ΡΠ΅Π°Π½ΠΈΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΎΠ². ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΡΠΈΡΡΠΎΡΠΊΠΎΠΏΠΈΠΈ Ρ Π±ΠΈΠΎΠΏΡΠΈΠ΅ΠΉ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ Π½Π° Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΠΎΠΌ ΡΡΠ°ΠΏΠ΅, ΡΠ°Π½Π½ΡΡ ΠΌΠ°ΠΊΡΠΎ- ΠΈ ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΎΡΠ΅Π½ΠΊΠ° ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΎΡΠ΅Π½ΠΈΡΡ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ°ΠΊΡΠΎΡΡ ΡΠΈΡΠΊΠ° ΠΈ ΡΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°ΡΡ ΡΠ°Π΄ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΡΠ°Π½Π½Π΅ΠΉ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ ΠΈ ERAS-ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΡΡΡΡ Π² ΠΎΠ½ΠΊΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅ ΡΠ΅Π΄ΠΊΠΎ ΠΈ Π½Π΅ Π² ΠΏΠΎΠ»Π½ΠΎΠΌ ΠΎΠ±ΡΠ΅ΠΌΠ΅. ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΠ»Π΅ΠΌΠ΅Π½ΡΠΎΠ² ERAS-ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Π° Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΎΠΏΡΡ
ΠΎΠ»ΡΠΌΠΈ ΠΌΠΎΡΠ΅Π²ΠΎΠ³ΠΎ ΠΏΡΠ·ΡΡΡ Π½Π΅ ΡΡΠ΅Π±ΡΠ΅Ρ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΡ
Π·Π°ΡΡΠ°Ρ, ΡΠΎΠΊΡΠ°ΡΠ°Π΅Ρ ΡΡΠΎΠΊΠΈ ΠΏΡΠ΅Π±ΡΠ²Π°Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² ΡΠ΅Π°Π½ΠΈΠΌΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠΈ Π½Π° 1-2 ΡΡΡΠΎΠΊ
Bladder cancer and the use of the fast track method in the early rehabilitation of oncological patients (literature review)
In the last 20 years, a concept of using multimodal programs of early rehabilitation of patients after surgical interventions β Enhanced Recovery After Surgery (ERAS) β has been developed in medicine. In oncological urology, the ERAS protocol is used only in treatment of bladder cancer. At the same time, not all available elements of this program are used despite the fact that in Russia 24.4 % of malignant tumors are urogenital tumors, and bladder cancer comprises one sixth (4.6 %) of them. Frequently, reconstructive plastic surgery is an integral part of bladder cancer treatment, and itβs accompanied by various complications many of which are associated with incorrect tactics of perioperative patient care. This situation can be dramatically improved by a more widespread use of the ERAS protocol. The immediate problemΒ of oncological urology is development of an effective, safe, and available for wide use algorithm of postoperative rehabilitation of patients with malignant tumors of the bladder after cystectomy with cystoplasty